Clofibrate-induced apoptosis is mediated by Ca2+-dependent caspase-12 activation

被引:17
作者
Matzno, S [1 ]
Yasuda, S [1 ]
Kitada, Y [1 ]
Akiyoshi, T [1 ]
Tanaka, N [1 ]
Juman, S [1 ]
Shinozuka, K [1 ]
Nakabayashi, T [1 ]
Matsuyama, K [1 ]
机构
[1] Mukogawa Womens Univ, Sch Pharmaceut Sci, Dept Biochem 1, Nishinomiya, Hyogo 6638179, Japan
关键词
clofibrate; myopathy; apoptosis; calcium influx;
D O I
10.1016/j.lfs.2005.08.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The mechanism of fibrate-induced myopathy was investigated in this report. When clofibrate (30 to 300 mu M) was applied to L6 rat skeletal myoblasts, dose-dependently apoptosis was observed within 24 h. In the apoptotic myoblasts, a caspase-12 cleavage was observed at 2 It and with following caspases-9 and -3-related cascade activation. In contrast, the neutral protease calpain, that is a key enzyme in ER stress-related apoptosis via caspase-12 activation, was significantly decreased during apoptosis. Next, the authors evaluated a role of calcium-dependent signal(s). When clofibrate was added into medium, cytosolic calcium concentration was rapidly and persistently increased. On the other hand, an addition of 10 mM EGTA depressed sustained calcium phase, and concurrent myoblasts apoptosis was completely inhibited. Taken together, our findings indicate that the clofibrate-induced myopathy is triggered by Ca2+ influx, then activated cytosolic caspase-12 through calpain-independent cascade, and consequently caused apoptotic DNA fragmentation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1892 / 1899
页数:8
相关论文
共 44 条
[1]   Risk of adverse events with fibrates [J].
Alsheikh-Ali, AA ;
Kuvin, JT ;
Karas, RH .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) :935-+
[2]   Calsequestrin and the calcium release channel of skeletal and cardiac muscle [J].
Beard, NA ;
Laver, DR ;
Dulhunty, AF .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2004, 85 (01) :33-69
[3]  
Chow L T, 1994, Chin Med Sci J, V9, P129
[4]   Antiretroviral protease inhibitors prevent L6 muscle cell fusion by reducing calpain activity [J].
Colby-Germinario, SP ;
Chalifour, LE ;
Antonecchia, A ;
Germinario, RJ .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (10) :1057-1062
[5]   Calpain and myogenesis: development of a convenient cell culture model [J].
Dedieu, S ;
Dourdin, N ;
Dargelos, E ;
Poussard, S ;
Veschambre, P ;
Cottin, P ;
Brustis, JJ .
BIOLOGY OF THE CELL, 2002, 94 (02) :65-76
[6]   Molecular pathways of protein synthesis inhibition during brain reperfusion: Implications for neuronal survival or death [J].
DeGracia, DJ ;
Kumar, R ;
Owen, CR ;
Krause, GS ;
White, BC .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (02) :127-141
[7]   Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs [J].
Graham, DJ ;
Staffa, JA ;
Shatin, D ;
Andrade, SE ;
Schech, SD ;
La Grenade, L ;
Gurwitz, JH ;
Chan, KA ;
Goodman, MJ ;
Platt, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2585-2590
[8]   Micronized fenofibrate: A new fibric acid hypolipidemic agent [J].
Guay, DRP .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (10) :1083-1103
[9]   Myopathy and rhabdomyolysis with lipid-lowering drugs [J].
Hodel, C .
TOXICOLOGY LETTERS, 2002, 128 (1-3) :159-168
[10]   Properties of Ca2+ release induced by clofibric acid from the sarcoplasmic reticulum of mouse skeletal muscle fibres [J].
Ikemoto, T ;
Endo, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :719-728